These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25341659)

  • 1. Protein folding activity of the ribosome (PFAR) -- a target for antiprion compounds.
    Banerjee D; Sanyal S
    Viruses; 2014 Oct; 6(10):3907-24. PubMed ID: 25341659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiprion compound 6-aminophenanthridine inhibits the protein folding activity of the ribosome by direct competition.
    Pang Y; Kurella S; Voisset C; Samanta D; Banerjee D; Schabe A; Das Gupta C; Galons H; Blondel M; Sanyal S
    J Biol Chem; 2013 Jun; 288(26):19081-9. PubMed ID: 23673663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The various facets of the protein-folding activity of the ribosome.
    Voisset C; Saupe SJ; Blondel M
    Biotechnol J; 2011 Jun; 6(6):668-73. PubMed ID: 21567961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Folding Activity of the Ribosome is involved in Yeast Prion Propagation.
    Blondel M; Soubigou F; Evrard J; Nguyen PH; Hasin N; Chédin S; Gillet R; Contesse MA; Friocourt G; Stahl G; Jones GW; Voisset C
    Sci Rep; 2016 Sep; 6():32117. PubMed ID: 27633137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship study around guanabenz identifies two derivatives retaining antiprion activity but having lost α2-adrenergic receptor agonistic activity.
    Nguyen PH; Hammoud H; Halliez S; Pang Y; Evrard J; Schmitt M; Oumata N; Bourguignon JJ; Sanyal S; Beringue V; Blondel M; Bihel F; Voisset C
    ACS Chem Neurosci; 2014 Oct; 5(10):1075-82. PubMed ID: 25244284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectroscopic and DFT studies on 6-aminophenanthridine and its derivatives provide insights in their activity towards ribosomal RNA.
    Banerjee D; Vovusha H; Pang Y; Oumata N; Sanyal B; Sanyal S
    Biochimie; 2014 Feb; 97():194-9. PubMed ID: 24184272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The double life of the ribosome: When its protein folding activity supports prion propagation.
    Voisset C; Blondel M; Jones GW; Friocourt G; Stahl G; Chédin S; Béringue V; Gillet R
    Prion; 2017 Mar; 11(2):89-97. PubMed ID: 28362551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of the antiprion drugs 6AP and GA on ribosome assisted protein folding.
    Reis SD; Pang Y; Vishnu N; Voisset C; Galons H; Blondel M; Sanyal S
    Biochimie; 2011 Jun; 93(6):1047-54. PubMed ID: 21396977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Procedure for identification and characterization of drugs efficient against mammalian prion: from a yeast-based antiprion drug screening assay to in vivo mouse models.
    Voisset C; Saupe SJ; Galons H; Blondel M
    Infect Disord Drug Targets; 2009 Feb; 9(1):31-9. PubMed ID: 19200013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of conjugates of 6-aminophenanthridine and guanabenz, two structurally unrelated prion inhibitors, for the determination of their cellular targets by affinity chromatography.
    Gug F; Oumata N; Tribouillard-Tanvier D; Voisset C; Desban N; Bach S; Blondel M; Galons H
    Bioconjug Chem; 2010 Feb; 21(2):279-88. PubMed ID: 20092293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein folding activity of ribosomal RNA is a selective target of two unrelated antiprion drugs.
    Tribouillard-Tanvier D; Dos Reis S; Gug F; Voisset C; Béringue V; Sabate R; Kikovska E; Talarek N; Bach S; Huang C; Desban N; Saupe SJ; Supattapone S; Thuret JY; Chédin S; Vilette D; Galons H; Sanyal S; Blondel M
    PLoS One; 2008 May; 3(5):e2174. PubMed ID: 18478094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.
    Barbezier N; Chartier A; Bidet Y; Buttstedt A; Voisset C; Galons H; Blondel M; Schwarz E; Simonelig M
    EMBO Mol Med; 2011 Jan; 3(1):35-49. PubMed ID: 21204267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The toll-like receptor agonist imiquimod is active against prions.
    Oumata N; Nguyen PH; Beringue V; Soubigou F; Pang Y; Desban N; Massacrier C; Morel Y; Paturel C; Contesse MA; Bouaziz S; Sanyal S; Galons H; Blondel M; Voisset C
    PLoS One; 2013; 8(8):e72112. PubMed ID: 23977222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive drug guanabenz is active in vivo against both yeast and mammalian prions.
    Tribouillard-Tanvier D; Béringue V; Desban N; Gug F; Bach S; Voisset C; Galons H; Laude H; Vilette D; Blondel M
    PLoS One; 2008 Apr; 3(4):e1981. PubMed ID: 18431471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural insight into the antiprion compound inhibition mechanism of native prion folding over misfolding.
    Choi J; Govindaraj RG; Hyeon JW; Lee K; Ma S; Kim SY; Lee J; No KT
    Chem Biol Drug Des; 2017 Jun; 89(6):907-917. PubMed ID: 27933736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ribosomal RNA Modulates Aggregation of the
    Pang Y; Kovachev P; Sanyal S
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32882892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic identification of antiprion drugs by high-throughput screening based on scanning for intensely fluorescent targets.
    Bertsch U; Winklhofer KF; Hirschberger T; Bieschke J; Weber P; Hartl FU; Tavan P; Tatzelt J; Kretzschmar HA; Giese A
    J Virol; 2005 Jun; 79(12):7785-91. PubMed ID: 15919931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.
    Bamia A; Sinane M; Naït-Saïdi R; Dhiab J; Keruzoré M; Nguyen PH; Bertho A; Soubigou F; Halliez S; Blondel M; Trollet C; Simonelig M; Friocourt G; Béringue V; Bihel F; Voisset C
    Neurotherapeutics; 2021 Apr; 18(2):1137-1150. PubMed ID: 33533011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variety of antiprion compounds discovered through an in silico screen based on cellular-form prion protein structure: Correlation between antiprion activity and binding affinity.
    Hosokawa-Muto J; Kamatari YO; Nakamura HK; Kuwata K
    Antimicrob Agents Chemother; 2009 Feb; 53(2):765-71. PubMed ID: 19015328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small Molecules with Anti-Prion Activity.
    Mustazza C; Sbriccoli M; Minosi P; Raggi C
    Curr Med Chem; 2020; 27(33):5446-5479. PubMed ID: 31560283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.